ResearcherSheng Jing HospitalNo recent work listed
Shaolong Sun
Matched on ORCID iD 0000-0002-9817-7781; OpenAlex author ID A5037745205. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 1, last author 5)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 9
2014: 2 papers · 2015: 1 paper · 2016: none · 2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: 2 papers
Papers 7
- Sodium channel 1 subunit alpha SCNN1A exerts oncogenic function in pancreatic cancer via accelerating cellular growth and metastasis. Last author DOI 10.1016/j.abb.2022.109323↗
- Deubiquitinase ubiquitin-specific peptidase 10 maintains cysteine rich angiogenic inducer 61 expression via Yes1 associated transcriptional regulator to augmen… Last author DOI 10.1111/cas.15326↗
- A novel tp53-associated nomogram to predict the overall survival in patients with pancreatic cancer. Last author DOI 10.1186/s12885-021-08066-2↗
- Expression of Beclin 1 and Bcl-2 in pancreatic neoplasms and its effect on pancreatic ductal adenocarcinoma prognosis. Last author DOI 10.3892/ol.2017.7218↗
- Long-Term Diabetes Mellitus Is Associated with an Increased Risk of Pancreatic Cancer: A Meta-Analysis. Last author DOI 10.1371/journal.pone.0134321↗
- Analysis of dysregulation of immune system in pancreatic cancer based on gene expression profile. First author DOI 10.1007/s11033-014-3307-2↗
- Identification of genes and candidate agents associated with pancreatic cancer. Co-author DOI 10.1007/s13277-013-1009-3↗
Closest collaborators
The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Baosheng Wang · 4 shared papers, 2014–2017 · strength 0.28
- Paper Expression of Beclin 1 and Bcl-2 in pancreatic neoplasms and its effect on pancreatic ductal adenocarcinoma prognosis. DOI 10.3892/ol.2017.7218↗
- Paper Analysis of dysregulation of immune system in pancreatic cancer based on gene expression profile. DOI 10.1007/s11033-014-3307-2↗
- Paper Identification of genes and candidate agents associated with pancreatic cancer. DOI 10.1007/s13277-013-1009-3↗
- Xun Liu · 1 shared paper, 2022 · strength 0.20
- Xun Liu · 1 shared paper, 2021 · strength 0.19
- Dan Wang · 1 shared paper, 2022 · strength 0.19
- Feng Gao · 1 shared paper, 2022 · strength 0.19
- Yunhao Wu · 1 shared paper, 2022 · strength 0.19
- Shanshan Song · 2 shared papers, 2015–2017 · strength 0.15
- Zhen Liu · 2 shared papers, 2014 · strength 0.13
- Yi Zhao · 1 shared paper, 2014 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.